Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.

Stoke Therapeutics Inc
Start price
€28.80
20.03.26 / 50%
Target price
€51.88
20.03.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 20.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time.
Performance without dividends (%)
Name 1w
Stoke Therapeutics Inc -
iShares Core DAX® -4.932%
iShares Nasdaq 100 -2.634%
iShares Nikkei 225® -4.733%
iShares S&P 500 -2.544%

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Stoke Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -
Target price 51.876
Change
Ends at 20.03.27

Stoke Therapeutics (STOK) had its price target raised by Canaccord Genuity Group Inc. from $36.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat

Canaccord Genuity Group Inc. 
0
Report Share
20.03.26

Stopped prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€8.85
28.04.23
€21.78
28.04.24
28.81%
29.04.24

Canaccord Genuity Group Inc. 
28.04.23 50%